Steve Lutz – Chief Executive Officer

Steve has had an exceptional career in all aspects of pharma business and commercialization. A founder of Praelia Pharmaceuticals, Steve was able to direct and develop a new health care entity into both the consumer and prescription pharmaceutical arenas.   With Cornerstone Therapeutics, Steve was Executive Vice President, of Operations as well as a founding stockholder. He was President of Aristos, Cornerstone’s generics division and achieved $40m of net profit in its first two years of operations. Steve has held various executive positions in the industry including Director, Trade Sales for Verum and acted as National Account Manager for both Biovail and Shire.  Steve holds a B.A. in Political Science and Sociology from Moravian College in Bethlehem, Pennsylvania.


Chenyqua Baldwin Shepard – Chief Financial Officer

As Chief Financial Officer, Chenyqua has full responsibility for all financial controls and reporting within Vestiq and is intimately familiar with EDI and the intricacies of accounting for drug distribution through multiple channels and through separated independent entities.  She also held the same position at Praelia Pharmaceuticals.  Chenyqua was Chief Accounting Officer, Controller and VP Finance for Cornerstone Therapeutics, Inc., as well as Director of Finance for Biovail.  Chenyqua is a fully accredited CPA with a Masters of Accounting degree and a Bachelor of Science, Business Administration Degree, both from the University of North Carolina.


Wade A. Harper – Executive Vice President of Commercial Operations

Wade Harper is a co-founder of Praelia Pharmaceuticals where he also served as Executive Vice President, Sales.  Prior to his work at Praelia, Mr. Harper served as National Sales Director for both the office-based and hospital-based sales forces at Cornerstone Therapeutics, Inc. While at Cornerstone, Mr. Harper also managed Sales Operations and Sales Analytics and acted as Regional Sales Manager.  Mr. Harper held several additional roles throughout his 15 years in the pharmaceutical industry including sales, training and management positions with both Dura and Elan Pharmaceuticals.